Compounds > azacitidine

azacitidine and Leukemia, Monocytic, Acute

azacitidine has been researched along with Leukemia, Monocytic, Acute in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19903 (25.00)18.7374
1990's1 (8.33)18.2507
2000's0 (0.00)29.6817
2010's7 (58.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Sato, S; Tamai, Y1
Jiang, X; Li, R; Lu, Z; Sun, Y; Wang, X; Xiao, X; Xiao, Y; Xu, Q; Zhang, G1
Grigoriadis, G; Tedjaseputra, A; Vilcassim, FS1
Kurokawa, M; Nannya, Y1
Cen, J; Chen, Z; Gu, W; Hu, S; Qiu, G; Wang, R; Wei, J; Xiang, L; Xie, X1
Almstedt, M; Blagitko-Dorfs, N; Duque-Afonso, J; Jäger, E; Karbach, J; Lübbert, M; Pfeifer, D1
Balgobind, BV; Baruchel, A; Cloos, J; Coenen, EA; Danen-van Oorschot, AA; de Bont, ES; de Haas, V; den Boer, ML; Kaspers, GJ; Kuipers, JE; Marschalek, R; Meyer, C; Pieters, R; Reinhardt, D; Stary, J; van den Heuvel-Eibrink, MM; Zwaan, CM1
Bernal, T; Gutiérrez-Fernández, A; Moncada-Pazos, A; Soria-Valles, C1
Attadia, V; Di Fiore, PP; Ferrara, F; Fusco, A; Pinto, A; Spada, OA1
Attadia, V1
Lichtenfeld, KM; Van Echo, DA; Wiernik, PH1
Baehner, RL; Berkow, RL; Weetman, RM; Weisman, SJ1

Other Studies

12 other study(ies) available for azacitidine and Leukemia, Monocytic, Acute

ArticleYear
Acute monocytic leukemia with histiocytic morphology in hematological remission after azacytidine and venetoclax therapy.
    International journal of hematology, 2022, Volume: 115, Issue:3

    Topics: Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Child; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Sulfonamides

2022
5‑aza‑2'‑deoxycytidine promotes migration of acute monocytic leukemia cells via activation of CCL2‑CCR2‑ERK signaling pathway.
    Molecular medicine reports, 2017, Volume: 16, Issue:2

    Topics: Azacitidine; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CCL2; Decitabine; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Leukemia, Monocytic, Acute; MAP Kinase Signaling System; Receptors, CCR2

2017
Ocular infiltration as initial presentation of acute monocytic leukaemia transformed from chronic myelomonocytic leukaemia associated with
    BMJ case reports, 2019, Mar-31, Volume: 12, Issue:3

    Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Cell Transformation, Neoplastic; Exophthalmos; Fatal Outcome; Humans; Leukemia, Monocytic, Acute; Leukemia, Myelomonocytic, Chronic; Leukemic Infiltration; Male; Mutation; Proto-Oncogene Proteins B-raf; Retina; Retinal Diseases

2019
[Acute myeloid leukemia].
    Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 8

    Topics: Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Azacitidine; fms-Like Tyrosine Kinase 3; Gemtuzumab; Humans; Leukemia, Monocytic, Acute; Molecular Targeted Therapy; Tretinoin

2012
Retinoic acid receptor-β gene reexpression and biological activity in SHI-1 cells after combined treatment with 5-aza-2'-deoxycytidine and all-trans retinoic acid.
    Acta haematologica, 2015, Volume: 133, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azacitidine; Cell Differentiation; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Monocytic, Acute; Receptors, Retinoic Acid; Tretinoin

2015
The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells.
    Leukemia research, 2010, Volume: 34, Issue:7

    Topics: Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Chromosomes, Human, X; Decitabine; DNA Methylation; DNA, Neoplasm; Gene Expression Regulation, Leukemic; Genes, X-Linked; HL-60 Cells; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Melanoma-Specific Antigens; Membrane Proteins; Multiple Myeloma; Neoplasm Proteins; RNA, Messenger; RNA, Neoplasm; U937 Cells

2010
High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23).
    Blood, 2011, Jan-20, Volume: 117, Issue:3

    Topics: Adolescent; Azacitidine; Blotting, Western; Cell Adhesion Molecule-1; Cell Adhesion Molecules; Cell Line, Tumor; Child; Child, Preschool; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Decitabine; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Profiling; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Immunoglobulins; Infant; Infant, Newborn; Leukemia, Monocytic, Acute; Male; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Survival Analysis; Translocation, Genetic

2011
Effects of azacitidine on matrix metalloproteinase-9 in acute myeloid leukemia and myelodysplasia.
    Experimental hematology, 2013, Volume: 41, Issue:2

    Topics: Aged; Aged, 80 and over; Anemia, Refractory, with Excess of Blasts; Antimetabolites; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Catalysis; Cell Line, Tumor; Disease Progression; DNA Methylation; Drug Resistance, Neoplasm; Enzyme Induction; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myelomonocytic, Acute; Male; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Second Primary; Promoter Regions, Genetic; Risk

2013
5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias.
    Blood, 1984, Volume: 64, Issue:4

    Topics: Azacitidine; Cell Differentiation; Cells, Cultured; Decitabine; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Neoplastic Stem Cells

1984
Effects of 5-aza-2'-deoxycytidine on differentiation and oncogene expression in the human monoblastic leukemia cell line U-937.
    Leukemia, 1993, Volume: 7 Suppl 1

    Topics: Antigens, Surface; Antineoplastic Agents; Azacitidine; Cell Adhesion; Cell Differentiation; Cell Division; Decitabine; DNA; Gene Expression Regulation, Neoplastic; Genes, fos; Genes, myc; Humans; Leukemia, Monocytic, Acute; Macrophages; Methylation; Monocytes; Tumor Cells, Cultured

1993
Vinblastine, 5-azacytidine, and VP-16-213 therapy for previously treated patients with acute nonlymphocytic leukemia.
    Cancer treatment reports, 1977, Volume: 61, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Agents; Azacitidine; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Vinblastine

1977
5-Azacytidine: acute central nervous system toxicity.
    The American journal of pediatric hematology/oncology, 1985,Spring, Volume: 7, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Central Nervous System; Child; Humans; Leukemia, Monocytic, Acute; Male; Nausea; Vomiting

1985